Medical Technology Breaking News: Aethlon Medical (OTCQB: AEMD) Announces Dr. Douglas Taylor as Chief Scientific Officer of Exosome Sciences, Inc.

SAN DIEGO - September 13, 2013 (Investorideas.com newswire) Aethlon Medical, Inc. (OTCBB:AEMD), announced today that Dr. Douglas Taylor has accepted the position of Chief Scientific Officer at Exosome Sciences, Inc. (ESI), a wholly owned diagnostic subsidiary of Aethlon Medical. Dr. Taylor is credited with the discovery of tumor-secreted exosomes and is a leading published author on the topic. "We are truly honored that Dr. Taylor has agreed to lead our research endeavors at Exosome Sciences. His pioneering research has been instrumental in establishing an industry for exosome-based diagnostics and therapeutics," stated Aethlon Chairman and CEO, Jim Joyce. The news was first reported through a presentation given by Mr. Joyce at the Exosomes & Circulating Biomarkers 2013 Summit. Mr. Joyce's presentation occurred after the close of market hours on September 12th.

Aethlon Medical develops therapeutic devices to address unmet medical needs in cancer, infectious disease, and other life-threatening conditions. The Company is preparing to launch the first U.S. studies of the Aethlon Hemopurifier® as a therapy to address hepatitis c virus (HCV) based on the recent approval of an Investigational Device Exemption (IDE) by the United States Food and Drug Administration (FDA). The Hemopurifier® is a first-in-class device that targets the rapid elimination of viruses and cancer glycopathogens, including disease-promoting exosomes from circulation.
Exosome Sciences was established by Aethlon to pursue exosome-based strategies to diagnose and monitor the progression of cancer, infectious disease and other life-threatening conditions. ESI's lead product, an Enzyme Linked Lectin Specific Assay (ELLSA) has been validated to identify the presence of exosomes underlying the human immunodeficiency virus (HIV), tuberculosis (TB), and various forms of cancer, including ovarian, melanoma, breast, lymphoma, and colorectal.
Dr. Taylor stated, "I am extremely excited about joining Exosome Sciences as their Chief Scientific Officer. I have been pioneering the field of exosome biology for more than 35 years and believe that exosomes represent the ideal disease marker due to their stability in the peripheral circulation and ability to be multiplexed. Exosome-based diagnostics will not only be used in identification and management of a variety of cancers, but also in other pathologies such as viral infections, pregnancy complications, birth defects, cardiovascular and neurodegenerative diseases. No other platform exhibits their potential for patient stratification and real-time monitoring of therapeutic responses. I have a long history of collaboration with scientists at Aethlon Medical and this opportunity will expand that interaction to bring ELLSA based assays to the clinic."
The release of exosomes by viable cells has been demonstrated in multiple cell types and systems. These nano-sized vesicles are detectable in biologic fluids, including blood, urine, ascites, and pleural fluids. They are essential mediators of normal homeostasis, based on their role in intercellular communication via surface interactions and transfer of macromolecules between cells. Cell injury or transformation is associated with alterations in the cell's exosome production and composition of these exosomes. This aberrant exosome composition can be utilized as surrogate markers of specific disease pathologies. The ESI mission is to advance an exosome-based biomarker platform to diagnose a broad-spectrum of disease conditions as well as monitor disease progression/regression in response to therapy as a means to improve patient management and outcomes. In the oncology field, ESI products will also be positioned to serve as companion diagnostics that determine when to initiate Hemopurifier® therapy or provide real-time monitoring of tumor responses to Hemopurifier® therapy.
About Dr. Taylor
Dr. Taylor discovered and pioneered the field of exosome biology and their role in intercellular communication and immune regulation. He has been in the Department of Obstetrics, Gynecology and Women's Health at the University of Louisville School of Medicine since 1992. Dr. Taylor published the initial article describing circulating tumor exosomes/microvesicles in 1979 (Anal. Biochem. 98:53-59, 1979). The research in his laboratory has primarily focused on the release and consequences of exosomes from gynecologic cancer and lung tumors. Over the past 30+ years, Dr Taylor has pioneered the isolation and characterization of circulating tumor-derived exosomes. His work has focused on characterization of circulating exosomes released by tumor cells for their role in immune regulation and induction of a pro-inflammatory tumor microenvironment. His work has demonstrated that the presence of specific circulating exosomal components have potential use as biomarkers for cancer patients.
About Aethlon Medical
Aethlon Medical creates innovative medical devices that address unmet medical needs in cancer, infectious disease, and other life-threatening conditions. Our Aethlon ADAPT™ System is a revenue-stage technology platform that provides the basis for a new class of devices the rapid, yet selective removal of disease promoting particles from the entire circulatory system. At present, The Aethlon ADAPT™ product pipeline includes the Aethlon Hemopurifier® to address infectious disease and cancer, and a medical device being developed under a 5-year contract with Defense Advanced Research Projects Agency (DARPA) to reduce the incidence of sepsis in combat-injured soldiers. For more information, please visit www.aethlonmedical.com.
Certain statements herein may be forward-looking and involve risks and uncertainties. Such forward-looking statements involve assumptions, known and unknown risks, uncertainties and other factors which may cause the actual results, performance or achievements of Aethlon Medical, Inc. to be materially different from any future results, performance, or achievements expressed or implied by the forward-looking statements. Such potential risks and uncertainties include, without limitation, that the company can successfully protect its intellectual property, that removal of exosomes from the human body will impact or lead to successful treatment of cancer, or that exosomes are the cause of tumor growth and progression, that the FDA will not approve the initiation of the Company's clinical programs or provide market clearance of the company's products, future human studies whether revenue or non-revenue generating of the Aethlon ADAPT™ system or the Aethlon Hemopurifier® as an adjunct therapy to improve patient responsiveness to established cancer or hepatitis C therapies or as a standalone cancer or hepatitis C therapy, the Company's ability to raise capital when needed, the Company's ability to complete the development of its planned products, the Company's ability to manufacture its products either internally or through outside companies and provide its services, the impact of government regulations, patent protection on the Company's proprietary technology, product liability exposure, uncertainty of market acceptance, competition, technological change, and other risk factors. In such instances, actual results could differ materially as a result of a variety of factors, including the risks associated with the effect of changing economic conditions and other risk factors detailed in the Company's Securities and Exchange Commission filings. The Company undertakes no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events, or otherwise.
Contacts:
James A. Joyce
Chairman and CEO
858.459.7800 x301
jj@aethlonmedical.com
Jim Frakes
Chief Financial Officer
858.459.7800 x300
jfrakes@aethlonmedical.com
Marc Robins
877.276.2467
mr@aethlonmedical.com
Published at Investorideas.com newswire
Sign up for the free investor news and stock alerts
http://www.investorideas.com/Resources/Newsletter.asp
Disclaimer / Disclosure : The Investorideas.com is a third party publisher of news and research Our sites do not make recommendations, but offer information portals to research news, articles, stock lists and recent research. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. Disclosure: Investorideas has been compensated by AEMD for news distribution and content publishing: three thousand per month effective June 2013
http://www.investorideas.com/About/Disclaimer.asp
This site is currently compensated by featured companies, news submissions and online advertising.
BC Residents and Investor Disclaimer : Effective September 15 2008 - all BC investors should review all OTC and Pink sheet listed companies for adherence in new disclosure filings and filing appropriate documents with Sedar

Apple's (AAPL) Adoption of Biometric Fingerprint Technology Will Play a Key Role in Changing Future of Mobile Security

New York, NY - September 12, 2013 (www.investorideas.com newswire) Investorideas.com, an investor research portal specializing in investing ideas in leading sectors including biometric and mobile security stocks issues a snapshot on key developments in the sector. Apple's (NASDAQ:AAPL) new iPhone 5s launch has everyone talking about biometrics and mobile security.

Apple reported "iPhone 5s introduces Touch ID, an innovative way to simply and securely unlock your iPhone with just the touch of a finger. Built into the home button, Touch ID uses a laser cut sapphire crystal, together with the capacitive touch sensor, to take a high-resolution image of your fingerprint and intelligently analyze it to provide accurate readings from any angle. Setting up Touch ID to recognize your fingerprint is easy, and every time you use it, it gets better. The Touch ID sensor recognizes the touch of a finger so the sensor is only activated when needed, preserving battery life. All fingerprint information is encrypted and stored securely in the Secure Enclave inside the A7 chip on the iPhone 5s; it’s never stored on Apple servers or backed up to iCloud®. Touch ID can also be used as a secure way to approve purchases from the iTunes Store®, App Store or iBooks Store."
Gartner Research projects worldwide mobile payment transactions will exceed $235 billion in 2013, reaching $721 billion in annual transactions with more than 450 million users by 2017. That creates a big opportunity for companies in the mobile security space.
Apple (NASDAQ:AAPL), always known as first to market and an innovator, apparently plans to integrate the fingerprint scanners into the iPhone 6 to address consumer concerns over mobile payment security.
How significant is the biometrics acquisition for Apple? Wells Fargo analyst raised its forecast for Apple based on the biometrics integration.
"We believe investors may be under- appreciating Apple's (NASDAQ:AAPL) Authentec acquisition--specifically the ability to perform secure device-side authentication, which could help open up the mCommerce market and further penetrate the enterprise market," said Wells Fargo analyst Maynard Um.
NXT-ID, Inc. (OTCQB: NXTD), a new player on the scene in payment security, is launching the Wocket this fall; a unique technology takes a very different approach: Instead of replacing the wallet, they are improving it! The Wocket™ reduces the number of cards in a consumer's wallet while supporting virtually every payment method currently available at Point-of-Sale (POS) at retailers around the world including magnetic stripe, EMV/NFC and barcode…all within a secure vault within a wallet. The company then plans to roll out a full suite of MobileBio™ technologies for mobile applications including its 3D Facial recognition technology.
NXT-ID, Inc.'s MobileBio™ facematch™ is a modular facial recognition platform technology that can be applied to a variety of platforms including smartphones, tablets, laptops and desktop computers. Depending on the number of cameras available and level of security desired, facematch™ will use 2D, pseudo 3D or 3D facial recognition algorithms to allow the user access to their device, data, or door. facematch™ supports both 3D and 2D camera devices, supporting various applications such as adding access control to a door or prison to adding superior authentication and/or encryption to a mobile device.
Samsung (KSE:oo5930) is also rumored to be integrating biometrics fingerprint technology in their smartphones and related devices. Samsung previously launched its biometric Face Unlock feature for Galaxy but the technology was easily fooled by photos from its users.
Precise Biometrics AB (PREC) recently had a big run following news of its deal with Fingerprint Cards. Precise Biometrics AB and Fingerprint Cards AB (FPC) announced they have entered into an agreement where FPC will license Precise Biometrics' fingerprint algorithm to further enhance the performance of FPC world leading capacitive sensors. FPC will bundle the algorithm into existing sensor products, primarily targeting mobile phones and tablets. The bundle will further enhance the performance of FPC sensors in terms of accuracy and speed which are important criteria especially in the fast growing mobile and tablet markets.
If Apple integrates biometrics successfully, the world as always, will follow and the race will be on for the search for the best and most secure biometrics technology for mobile users.
About InvestorIdeas.com: Big Ideas for global investors
InvestorIdeas.com is a leader in investor stock research by sector, featuring stock news, commentary and trading alerts in leading sectors including biotech, tech, mining, energy, water, renewable energy, beverage stocks and more.
Research Biometrics Stocks at Investorideas.com stock directory
http://www.investorideas.com/BPS/Stock_List.asp
Sign up for free stock alerts
http://www.investorideas.com/Resources/Newsletter.asp
Published at the Investorideas.com Newswire - Big ideas for Global Investors
Disclaimer/ Disclosure: The Investorideas.com newswire is a third party publisher of news and research as well as creates original content as a news source. Original content created by investorideas is protected by copyright laws other than syndication rights.  Investorideas is a news source on Google news and Linkedintoday plus hundreds of syndication partners. Our site does not make recommendations for purchases or sale of stocks or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investment involves risk and possible loss of investment. This site is currently compensated by featured companies, news submissions, content marketing and online advertising. Contact each company directly for press release questions. Disclosure is posted on each release if required but otherwise the news was not compensated for and is published for the sole interest of our readers. Disclosure: Investorideas has been compensated by NXTD: five thousand per month plus 144 shares.
More info : http://www.investorideas.com/About/Disclaimer.asp
BC Residents and Investor Disclaimer : Effective September 15 2008 - all BC investors should review all OTC and Pink sheet listed companies for adherence in new disclosure filings and filing appropriate documents with Sedar. Read for more info: http://www.bcsc.bc.ca/release.aspx?id=6894. Global investors must adhere to regulations of each country.
800-665-0411 - or 212-822-8842 Source - www.Investorideas.com

Medical Technology Breaking News: Aethlon Medical (OTCQB: AEMD) Announces Launch of Exosome Sciences Subsidiary

SAN DIEGO - September 12, 2013 (Investorideas.com newswire) Aethlon Medical, Inc. (OTCBB:AEMD), today announced the formal launch of Exosome Sciences, Inc. (ESI), a wholly-owned subsidiary previously established by Aethlon to pursue exosome-based strategies to diagnose and monitor the progression of cancer, infectious disease and other life-threatening conditions. Exosomes produced by diseased cells represent an optimal diagnostic target as they are shed into bodily fluids such as urine and blood where they can be easily accessed. Exosomes transport specific disease-origin markers that provide the basis for ESI to establish non-invasive liquid biopsies to diagnose and monitor a wide-range of disease conditions.

Aethlon Chairman and CEO, Jim Joyce stated, "As a therapeutic organization, our primary focus is the clinical advancement and future commercialization of the Aethlon Hemopurifer® in the United States and abroad. With this mind, our objective with ESI is to transform a currently dormant and unvalued diagnostic asset into a stand-alone organization that contributes measurable asset value to Aethlon shareholders, yet does not dilute our team's focus away from advancing first-in-class therapeutic devices. It also became clear that the launch of ESI might allow us to leverage recent valuations that have been awarded to molecular diagnostic organizations with novel technology strategies."
Aethlon disclosed that ESI's research facility is being established within a CLIA certified laboratory located in Langhorne, Pennsylvania. The facility is adjacent to the Philadelphia/New Jersey I-95 corridor, which is the home for numerous U.S. biopharmaceutical organizations, including Merck and Johnson & Johnson. The introduction of key ESI researchers who will lead the development and commercialization of next-generation diagnostics will occur through follow-on disclosures.
At present, Aethlon is preparing to launch the first U.S. studies of the Hemopurifier® as a therapy to address hepatitis c virus (HCV) based on the recent approval of an Investigational Device Exemption (IDE) by the United States Food and Drug Administration (FDA). The Hemopurifier is a first-in-class device that targets the rapid elimination of infectious disease and cancer glycopathogens, including exosomes from circulation. Exosomes enhance disease progression of viral infections and in cancer trigger apoptosis of immune cells and have been reported to facilitate tumor growth, metastasis, and the development of drug resistance.
Aethlon will contribute diagnostic related technology to ESI, including the Enzyme Linked Lectin Specific Assay (ELLSA), which has been validated to identify the presence of exosomes underlying the human immunodeficiency virus (HIV), tuberculosis (TB), and various forms of cancer, including ovarian, melanoma, breast, lymphoma, and colorectal. ELLSA was originally created by Aethlon researchers as a tool to help validate the ability of the Hemopurifier® to capture tumor-secreted exosomes. At the time, effective tools to isolate and quantify exosomes did not exist as few labs conducted exosome research. Since then, an increased understanding of the role of exosomes underlying a wide-range of disease conditions has created a demand for related diagnostic products. As part of the relationship, ESI has agreed to assign any therapeutic related discoveries back to Aethlon Medical. Beyond the potential for future technology advances by ESI researchers, ESI may also in-license related diagnostic IP from collaborative research partners.
The release of exosomes by viable cells has been demonstrated in multiple cell types and systems. These nano-sized vesicles are detectable in biologic fluids, including blood, urine, ascites, and pleural fluids. They are essential mediators of normal homeostasis, based on their role in intercellular communication via surface interactions and transfer of macromolecules between cells. Cell injury or transformation is associated with alterations in the cell's exosome production and composition of these exosomes. This aberrant exosome composition can be utilized as surrogate markers of specific disease pathologies. The ESI mission is to advance an exosome-based biomarker platform to diagnose a broad-spectrum of disease conditions as well as monitor disease progression/regression in response to therapy as a means to improve patient management and outcomes. In the oncology field, ESI products will also be positioned to serve as companion diagnostics that determine when to initiate Hemopurifier® therapy or provide real-time monitoring of tumor responses to Hemopurifier® therapy.
About Aethlon Medical
Aethlon Medical creates innovative medical devices that address unmet medical needs in cancer, infectious disease, and other life-threatening conditions. Our Aethlon ADAPT™ System is a revenue-stage technology platform that provides the basis for a new class of devices the rapid, yet selective removal of disease promoting particles from the entire circulatory system. At present, The Aethlon ADAPT™ product pipeline includes the Aethlon Hemopurifier® to address infectious disease and cancer, and a medical device being developed under a 5-year contract with Defense Advanced Research Projects Agency (DARPA) to reduce the incidence of sepsis in combat-injured soldiers. For more information, please visit www.aethlonmedical.com.
Certain statements herein may be forward-looking and involve risks and uncertainties. Such forward-looking statements involve assumptions, known and unknown risks, uncertainties and other factors which may cause the actual results, performance or achievements of Aethlon Medical, Inc. to be materially different from any future results, performance, or achievements expressed or implied by the forward-looking statements. Such potential risks and uncertainties include, without limitation, that the company can successfully protect its intellectual property, that removal of exosomes from the human body will impact or lead to successful treatment of cancer, or that exosomes are the cause of tumor growth and progression, that the FDA will not approve the initiation of the Company's clinical programs or provide market clearance of the company's products, future human studies whether revenue or non-revenue generating of the Aethlon ADAPT™ system or the Aethlon Hemopurifier® as an adjunct therapy to improve patient responsiveness to established cancer or hepatitis C therapies or as a standalone cancer or hepatitis C therapy, the Company's ability to raise capital when needed, the Company's ability to complete the development of its planned products, the Company's ability to manufacture its products either internally or through outside companies and provide its services, the impact of government regulations, patent protection on the Company's proprietary technology, product liability exposure, uncertainty of market acceptance, competition, technological change, and other risk factors. In such instances, actual results could differ materially as a result of a variety of factors, including the risks associated with the effect of changing economic conditions and other risk factors detailed in the Company's Securities and Exchange Commission filings. The Company undertakes no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events, or otherwise.
Contacts:
James A. Joyce
Chairman and CEO
858.459.7800 x301
jj@aethlonmedical.com
Jim Frakes
Chief Financial Officer
858.459.7800 x300
jfrakes@aethlonmedical.com
Marc Robins
877.276.2467
mr@aethlonmedical.com
Published at Investorideas.com newswire
Sign up for the free investor news and stock alerts
http://www.investorideas.com/Resources/Newsletter.asp
Disclaimer / Disclosure : The Investorideas.com is a third party publisher of news and research Our sites do not make recommendations, but offer information portals to research news, articles, stock lists and recent research. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. Disclosure: Investorideas has been compensated by AEMD for news distribution and content publishing: three thousand per month effective June 2013
http://www.investorideas.com/About/Disclaimer.asp
This site is currently compensated by featured companies, news submissions and online advertising.
BC Residents and Investor Disclaimer : Effective September 15 2008 - all BC investors should review all OTC and Pink sheet listed companies for adherence in new disclosure filings and filing appropriate documents with Sedar

The Growing Portable Power Generation Market: From Diesel to Natural Gas, Fuel Cells to Solar, the Global Demand is on the Rise

New York, NY - September 11, 2013 (Investorideas.com renewable energy stocks newswire) Investorideas.com, an investor research portal specializing in sector research for independent investors, including renewable energy stocks issues a sector snapshot for portable power generation stocks and the growing global market opportunity.

Diesel and gas power generators (Gensets) represent a bullish growing global industry according to research firm GlobalData, predicting the market will nearly double from $12 billion in 2011 to some $22.3 billion by 2020. GlobalData also says growth is being driven by an increasing need for safe and reliable off-grid power in numerous end markets.
Key growth areas to watch are India and China, with India growing from $1.2 billion to $2.54 billion by 2020 and China growing from $2.4 billion to nearly $5.5 billion by 2020.
According to an article in Forbes in late August following the report, "The projected market growth will likely benefit major industrial equipment vendors like Caterpillar (NYSE:CAT ) and Cummins (NYSE:CMI ) with a strong position in the distributed power space. But smaller companies like Scotland’s Aggreko with experience working in developing countries will also benefit.”
Briggs & Stratton Corporation (NYSE: BGG), with its wholly owned subsidiary that is North America's number one marketer of portable generators is also poised to benefit in the industry growth. The Company just released a news and media alert September 3rd entitled, "Portable, Standby Generators Play Powerful Role in National Preparedness Month."
As the market grows, energy efficiency and the role of renewable energy in the mix will also be key. From solar to fuel cells, new technology that represents a greener alternative will take a leading role.
Pike Research says that the current period of product development will lead to commercialization for portable fuel cells at an increasingly larger scale beginning in the 2015 timeframe.
A smaller player in the sector, Powerdyne International Inc. (OTCBB:PWDY) is aiming to meet greener standards while still being able to utilize traditional fuels. The company recently announced that it is expanding its reach in the renewable energy market through strategic relationships such as the recently formed agreement with Turning Mill Energy, of Sandwich, Massachusetts, a solar and wind company’.
The Powerdyne Genset uses a completely different type of engine that is small, powerful, light weight, portable, air cooled, runs on almost any gaseous fuel, environmentally green, and is easily maintained and serviced.
Dale Euga, President of Powerdyne International, Inc., stated, "Our companies will work together to offer large electrical users independent power generation, on-site. This lowers the user's cost of electricity without incurring expensive capital equipment costs."
Mr. Euga noted that, "The need for distributed electricity, using integrated and balanced technologies, is the key to continuing worldwide commercial growth."
Forbes article - http://www.forbes.com/sites/williampentland/2013/08/08/generator-demand-goes-gangbusters/
About InvestorIdeas.com:
InvestorIdeas.com is a leader in investor stock research by sector, featuring stock news, commentary and trading alerts in leading sectors including biotech, tech, mining, energy, water, renewable energy, beverage stocks and more.
Follow Investorideas.com on Twitter http://twitter.com/#!/Investorideas
Follow Investorideas.com on Facebook http://www.facebook.com/Investorideas
Follow Investorideas.com News on Linkedin.com/today at http://www.linkedin.com/today/investorideas.com
Sign up for renewable energy stock alerts http://www.investorideas.com/Resources/Newsletter.asp
Become an Investorideas.com Member and access our 14 online stock directories 24/7 - tech, social media stocks, biotech stocks, water, renewable energy stocks, mining stocks and more…
http://www.investorideas.com/membership/
Disclaimer/ Disclosure: The Investorideas.com newswire is a third party publisher of news and research as well as creates original content as a news source. Original content created by investorideas is protected by copyright laws other than syndication rights. Investorideas is a news source on Google news and Linkedintoday plus hundreds of syndication partners. Our site does not make recommendations for purchases or sale of stocks or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investment involves risk and possible loss of investment. This site is currently compensated by featured companies, news submissions, content marketing and online advertising. Contact each company directly for press release questions. Disclosure is posted on each release if required but otherwise the news was not compensated for and is published for the sole interest of our readers. More disclaimer info: http://www.investorideas.com/About/Disclaimer.asp. Disclosure: Investorideas.com newswire has been compensated two thousand dollars for one month of news and content distribution. BC Residents and Investor Disclaimer : Effective September 15 2008 - all BC investors should review all OTC and Pink sheet listed companies for adherence in new disclosure filings and filing appropriate documents with Sedar. Read for more info: http://www.bcsc.bc.ca/release.aspx?id=6894. Global investors must adhere to regulations of each country.
800-665-0411 - Source - www.Investorideas.com

As Apple (APPL) does others will Follow: Apple's Biometric Acquisition Will Play a Key Role in Changing the Face of Mobile Security

New York, NY - September 10, 2013 (www.investorideas.com newswire) Investorideas.com, an investor research portal specializing in investing ideas in leading sectors including biometric and mobile security stocks issues a snapshot on key developments in the sector. Apple's (NASDAQ:AAPL) acquisition of mobile security company AuthenTec for over $350 million has Wall Street and the industry buzzing about how biometric technology in smartphones will impact the global m-commerce market.

Gartner Research projects worldwide mobile payment transactions will exceed $235 billion in 2013, reaching $721 billion in annual transactions with more than 450 million users by 2017. That creates a big opportunity for companies in the mobile security space.
Apple (NASDAQ:AAPL), always known as first to market and an innovator, apparently plans to integrate the fingerprint scanners into the iPhone 6 to address consumer concerns over mobile payment security.
How significant is the biometrics acquisition for Apple? Wells Fargo analyst raised its forecast for Apple based on the biometrics integration.
"We believe investors may be under- appreciating Apple's (NASDAQ:AAPL) Authentec acquisition--specifically the ability to perform secure device-side authentication, which could help open up the mCommerce market and further penetrate the enterprise market," said Wells Fargo analyst Maynard Um.
NXT-ID, Inc. (OTCQB: NXTD), a new player on the scene in payment security, is launching the Wocket this fall; a unique technology takes a very different approach: Instead of replacing the wallet, they are improving it! The Wocket™ reduces the number of cards in a consumer's wallet while supporting virtually every payment method currently available at Point-of-Sale (POS) at retailers around the world including magnetic stripe, EMV/NFC and barcode…all within a secure vault within a wallet. The company then plans to roll out a full suite of MobileBio™ technologies for mobile applications including its 3D Facial recognition technology.
NXT-ID, Inc.'s MobileBio™ facematch™ is a modular facial recognition platform technology that can be applied to a variety of platforms including smartphones, tablets, laptops and desktop computers. Depending on the number of cameras available and level of security desired, facematch™ will use 2D, pseudo 3D or 3D facial recognition algorithms to allow the user access to their device, data, or door. facematch™ supports both 3D and 2D camera devices, supporting various applications such as adding access control to a door or prison to adding superior authentication and/or encryption to a mobile device.
Samsung (KSE:oo5930) is also rumored to be integrating biometrics fingerprint technology in their smartphones and related devices. Samsung previously launched its biometric Face Unlock feature for Galaxy but the technology was easily fooled by photos from its users.
Precise Biometrics AB (PREC) recently had a big run following news of its deal with Fingerprint Cards. Precise Biometrics AB and Fingerprint Cards AB (FPC) announced they have entered into an agreement where FPC will license Precise Biometrics' fingerprint algorithm to further enhance the performance of FPC world leading capacitive sensors. FPC will bundle the algorithm into existing sensor products, primarily targeting mobile phones and tablets. The bundle will further enhance the performance of FPC sensors in terms of accuracy and speed which are important criteria especially in the fast growing mobile and tablet markets.
If Apple integrates biometrics successfully, the world as always, will follow and the race will be on for the search for the best and most secure biometrics technology for mobile users.
About InvestorIdeas.com: Big Ideas for global investors
InvestorIdeas.com is a leader in investor stock research by sector, featuring stock news, commentary and trading alerts in leading sectors including biotech, tech, mining, energy, water, renewable energy, beverage stocks and more.
Research Biometrics Stocks at Investorideas.com stock directory
http://www.investorideas.com/BPS/Stock_List.asp
Sign up for free stock alerts
http://www.investorideas.com/Resources/Newsletter.asp
Published at the Investorideas.com Newswire - Big ideas for Global Investors
Disclaimer/ Disclosure: The Investorideas.com newswire is a third party publisher of news and research as well as creates original content as a news source. Original content created by investorideas is protected by copyright laws other than syndication rights.  Investorideas is a news source on Google news and Linkedintoday plus hundreds of syndication partners. Our site does not make recommendations for purchases or sale of stocks or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investment involves risk and possible loss of investment. This site is currently compensated by featured companies, news submissions, content marketing and online advertising. Contact each company directly for press release questions. Disclosure is posted on each release if required but otherwise the news was not compensated for and is published for the sole interest of our readers. Disclosure: Investorideas has been compensated by NXTD: five thousand per month plus 144 shares.
More info : http://www.investorideas.com/About/Disclaimer.asp
BC Residents and Investor Disclaimer : Effective September 15 2008 - all BC investors should review all OTC and Pink sheet listed companies for adherence in new disclosure filings and filing appropriate documents with Sedar. Read for more info: http://www.bcsc.bc.ca/release.aspx?id=6894. Global investors must adhere to regulations of each country.
800-665-0411 - or 212-822-8842 Source - www.Investorideas.com

Australian based Jenepe Asset Management launches new IPO fund

September 6, 2013 (www.investorideas.com newswire) Australian based investment house Jenepe Asset Management, in joint venture with London based IPO Capital Partners, has launched a fund targeting new listing opportunities.

The Certified Investment Management Analyst (CIMA) regulated fund, Jenepe IPO Capital Fund S.P., domiciled offshore in the Cayman Islands, will be managed by Nicholas Pereza-Mathews and will take positions in range of financial instruments focused on the Pre-IPO sector.
Mr Pereza-Mathews, who has over twenty years' experience in global markets and funds management working in London and Australasia, previously managed the Australian Natural Resources Fund, a top performing fund within its class achieving sound Alpha returns under his stewardship.
Mr Pereza-Mathews says the IPO sector has vast potential for growth given there has been a lack of capital commitment available for new listings since the GFC, with IPO's falling off dramatically each year.
"Our process is driven by performance and not asset gathering, aiming to provide capital appreciation over the medium term," Mr Pereza-Mathews says.
"As a seed to IPO fund we will be able to invest at an early stage of a companies intended listing which should generate significant returns when the companies complete a stock exchange listing."
"This is achieved by investing in a diversified range of securities ranging from early stage growth companies through to established companies seeking to list on a global recognised investment exchange within a 12 month period."
The fund's investment process is driven by a security selection process based on ascertaining the suitability of an investment through an in-depth assessment of commercial and financial aspects of each opportunity, screened by Jenepes' Investment Committee due diligence process.
IPO Capital Partner's Clifford Giles says we are excited about the new opportunities presented with the Jenepe IPO Capital Fund and Jenepe Asset Management team.
"We look forward to adding value to the team from our London base as we approach our next growth phase."
Mr Pereza-Mathews says once identified, opportunities are screened to ensure they are of an investment grade.
"A full assessment of the proposed investment is completed to establish whether the business is of a suitable quality and attractively priced," Mr Pereza-Mathews says.
"Jenepe is a focused investment manager seeking to provide superior investment returns for institutional and sophisticated investors, managed by an experienced team with an established track record of investing in seed and IPOs."
Jenepe also offers Global Markets and Foreign Exchange dealing and Capital Raising for sophisticated and institutional investors, with the aim to deliver profitable outcomes for clients from the one provider.
For more information go to www.jenepe.com
Media enquiries contact
Bruce Nelson on +61 423 403 449
About Jenepé
Jenepé Group is a boutique investment house which has office locations in Melbourne, Perth, Gold Coast and London offering globally a range of corporate financial services: including Funds Management, Global Markets wholesale brokerage, Forex trading, Stock Exchange listings, Capital Raising, Corporate Communications, Corporate Compliance Services and Prospectus Preparation.

Mining Stock Alert: SilverCrest (TSX.V: SVL) (NYSE MKT: SVLC) Reports Additional Drill Results at Santa Elena Mine; Another Discovery and More High Grade Intercepts, 15 metres @ 4 gpt Au and 243 gpt Ag including 2 metres @ 17.5 gpt Au and 664 gpt Ag

Vancouver, British Columbia - September 5, 2013 (Investorideas.com Mining Stocks Newswire) SilverCrest Mines Inc. (TSX.V:SVL) ( NYSE MKT: SVLC) is pleased to announce further results of delineation drilling at the Santa Elena Mine in Sonora, Mexico. A total of 181 core and RVC holes were completed in this program of which 134 holes were utilized in the recently announced “Santa Elena Pre-Feasibility Study and Update Reserve Technical Report” (Technical Report). Results for the remaining 47 holes reported in this news release were not available for inclusion in the revised Reserves and Resources for the Technical Report. The results show further expansion of the Santa Elena Deposit which is still open latterly and to depth (see attached Figures). Several of these reported holes identified additional high grade intercepts, expanded the recently discovered El Cholugo and El Cholugo Dos Zones, and also discovered a new zone called ”Tortuga”. Please refer to the Company website at www.silvercrestmines.com for further information.

N. Eric Fier, President and COO stated; “This delineation drill program at Santa Elena was immensely successful. With this program, we drilled the known portion of the deposit at approximately 35 metre centres, announced revised reserves and resources, extended mineralization beyond our current reserve boundary and identified three new zones, El Cholugo, El Cholugo Dos and the newly discovered Tortuga. The recently announced results of the revised underground reserve and resource estimations have extended the current mine life to a minimum of 8 years . Our underground ramp has progressed beyond 1,500 metres in development length. We have intercepted the Main Mineralized Zone underground and extracted approximately 8,000 tonnes of ore from the 625 metre level. The conventional mill construction and underground development currently underway are setting the stage for the successful expansion of the mine with an anticipated significant increase in metals production starting in 2014.”
Drill intercepts continue to expand the mineralization along the Main Mineralized Zone (MMZ) which remains open laterally and to depth. Intercepts are up to 100 metres beyond the boundary of current stope designs and reserves estimates. Most notable are the multiple high grade intercepts to the east and depth including;

• SE-13-144; 9.2 metres grading 4.83 gpt Au and 171.4 gpt Ag including 0.8 metres grading 30.20 gpt Au and 638.0 gpt Ag
• SE-13-152; 15.0 metres grading 4.03 gpt Au and 243.2 gpt Ag including 2.0 metres grading 17.5 gpt Au and 664.0 gpt Ag
• SE-13-160; 13.3 metres grading 3.52 gpt Au and 136.2 gpt Ag including 4.1 metres grading 6.46 gpt Au and 133.6 gpt Ag
• SE-13-166; 11.7 metres grading 3.97 gpt Au and 189.5 gpt Ag including 5.0 metres grading 8.10 gpt Au and 334.4 gpt Ag
• SE-13-175; 8.8 metres grading 1.91 gpt Au and 70.6 gpt Ag including 2.0 metres grading 6.70 gpt Au and 226.1 gpt Ag

The El Cholugo Zone continues to expand with 7 new drill hole intercepts. The dimensions of this newly discovered zone are now approximately 400 metres long by 200 metres high and the mineralization remains open to the west and to depth. A parallel mineralized zone (EL Cholugo Dos) was also intercepted with 3 new drill hole intercepts. Dimensions of this discovery are currently undetermined with further drilling anticipated to test this mineralization. Both of these zones will be easily accessible from planned underground development of the adjacent MMZ.
The new Tortuga Zone is a northwest trending vein, breccia and stockwork zone outcropping on the surface and in the pit (see attached Figure). This zone is similar in mineralogy to the Main Mineralized Zone which is currently being successfully mined. This discovery has been drilled within an estimated area of 200 metres long by 300 metres high with an average thickness of approximately 3 metres. Numerous mineralized veins parallel or sub-parallel to the discovery were also intersected in drilling and are under review as potential additional targets. Tortuga is exposed in the north wall of the pit making this discovery easily accessible from the open pit and planned underground development of the adjacent MMZ. Further work is planned at Tortuga for resources estimation and subsequent potential conversion to reserves.
Mineralized intervals reported range from 0.5 metres to 16.0 metres further supporting the proposed underground bulk mining approach at Santa Elena. All mineralized drill intercepts reported are near true thicknesses. The most significant assay results in this series of drill holes are shown in the following tables (all numbers are rounded);
TORTUGA (NEW DISCOVERY)
MAIN MINERALIZED ZONE (MMZ)
EL CHOLUGO
EL CHOLUGO DOS
All sample analyses were completed by ALS Chemex in Hermosillo, Mexico and North Vancouver, BC or the Santa Elena internal lab with checks at ALS Chemex.
Of the 47 holes being reported above only three holes, SE-12-100, 101 and 183, intercepted no significant assay results. Holes SE-12-97, 98 and 99 were previously announced only as general mineralized intercepts with results stated above. Holes SE-12-100 and 101 were not previous announced with their locations off trend and north of the deposit.
Approximately 58,493 metres of drilling were completed in the delineation program to convert underground resources to reserves, expand total resources and test further potential outside the results of the Pre-Feasibiity Study. One drill is currently on site completing an underground program (planned 1,500 metres) for detailed design of first production stopes anticipated to be mined in late 2014.
The Qualified Person under National Instrument (NI 43-101) Standards of Disclosure for Mineral Projects for this News Release is N. Eric Fier, CPG, P.Eng, President and Chief Operating Officer for SilverCrest Mines Inc., who has reviewed and approved its contents.
SilverCrest Mines Inc. (TSX VENTURE:SVL)(NYSE MKT:SVLC) is a Canadian precious metals producer headquartered in Vancouver, BC. SilverCrest's flagship property is the 100%-owned Santa Elena Mine, located 150 km northeast of Hermosillo, near Banamichi in the State of Sonora, México. The mine is a high-grade, epithermal silver and gold producer, with an estimated life of mine cash cost of US$8 per ounce of silver equivalent (55:1 Ag: Au). SilverCrest anticipates that the 2,500 tonnes per day open pit heap leach facility at the Santa Elena mine should recover approximately 625,000 ounces of silver and 33,000 ounces of gold in 2013. Major expansion and construction of a 3000 tonnes per day conventional mill facility is underway to significantly increase metals production at the Santa Elena Mine (open pit and underground) by 2014. Exploration programs continue to make new discoveries at Santa Elena and also have rapidly advanced the definition of a large polymetallic deposit at the La Joya property in Durango State with stated resources nearing 200 million ounces of Ag equivalent.
FORWARD-LOOKING STATEMENTS
This news release contains "forward-looking statements" within the meaning of Canadian securities legislation and the United States Securities Litigation Reform Act of 1995. Such forward-looking statements concern the Company's anticipated results and developments in the Company's operations in future periods, planned exploration and development of its properties, plans related to its business and other matters that may occur in the future. These statements relate to analyses and other information that are based on expectations of future performance, including silver and gold production and planned work programs. Statements concerning reserves and mineral resource estimates may also constitute forward-looking statements to the extent that they involve estimates of the mineralization that will be encountered if the property is developed and, in the case of mineral reserves, such statements reflect the conclusion based on certain assumptions that the mineral deposit can be economically exploited.
Forward-looking statements are subject to a variety of known and unknown risks, uncertainties and other factors which could cause actual events or results to differ from those expressed or implied by the forward-looking statements, including, without limitation: risks related to precious and base metal price fluctuations; risks related to fluctuations in the currency markets (particularly the Mexican peso, Canadian dollar and United States dollar); risks related to the inherently dangerous activity of mining, including conditions or events beyond our control, and operating or technical difficulties in mineral exploration, development and mining activities; uncertainty in the Company's ability to raise financing and fund the exploration and development of its mineral properties; uncertainty as to actual capital costs, operating costs, production and economic returns, and uncertainty that development activities will result in profitable mining operations; risks related to reserves and mineral resource figures being estimates based on interpretations and assumptions which may result in less mineral production under actual conditions than is currently estimated and to diminishing quantities or grades of mineral reserves as properties are mined; risks related to governmental regulations and obtaining necessary licenses and permits; risks related to the business being subject to environmental laws and regulations which may increase costs of doing business and restrict our operations; risks related to mineral properties being subject to prior unregistered agreements, transfers, or claims and other defects in title; risks relating to inadequate insurance or inability to obtain insurance; risks related to potential litigation; risks related to the global economy; risks related to the Company's status as a foreign private issuer in the United States; risks related to all of the Company's properties being located in Mexico and El Salvador, including political, economic, social and regulatory instability; and risks related to officers and directors becoming associated with other natural resource companies which may give rise to conflicts of interests. Should one or more of these risks and uncertainties materialize, or should underlying assumptions prove incorrect, actual results may vary materially from those described in the forward-looking statements. The Company's forward-looking statements are based on beliefs, expectations and opinions of management on the date the statements are made. For the reasons set forth above, investors should not place undue reliance on forward-looking statements.
The information provided in this news release is not intended to be a comprehensive review of all matters and developments concerning the Company. It should be read in conjunction with all other disclosure documents of the Company. The information contained herein is not a substitute for detailed investigation or analysis. No securities commission or regulatory authority has reviewed the accuracy or adequacy of the information presented.
N. Eric Fier
N. Eric Fier, President and COO
SILVERCREST MINES INC.
Contact:
SilverCrest Mines Inc.
Fred Cooper
(604) 694-1730 ext. 108
Toll Free: 1-866-691-1730
(604) 694-1761
info@silvercrestmines.com
www.silvercrestmines.com
Neither TSX Venture Exchange nor its Regulation Services Provider (as defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.
Published at Investorideas.com Newswire
Disclaimer / Disclosure : The Investorideas.com is a third party publisher of news and research Our sites do not make recommendations, but offer information portals to research news, articles, stock lists and recent research. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. This site is currently compensated by featured companies, news submissions and online advertising. Disclosure: SilverCrest Mines has compensated Investorideas.com for the distribution and publishing of this news release (annual news publication 9700) http://www.investorideas.com/About/Disclaimer.asp
BC Residents and Investor Disclaimer : Effective September 15 2008 - all BC investors should review all OTC and Pink sheet listed companies for adherence in new disclosure filings and filing appropriate documents with Sedar. Read for more info: http://www.bcsc.bc.ca/release.aspx?id=6894

Medical Technology Breaking News: Aethlon Medical (OTCQB: AEMD) to Present at Exosomes and Circulating Biomarkers 2013 Summit

SAN DIEGO - September 5, 2013 (Investorideas.com newswire) Aethlon Medical, Inc. (OTCBB:AEMD), announced today that Company Chairman and CEO, Jim Joyce has accepted an invitation to present at the Exosomes and Circulating Biomarkers 2013 Summit on September 12th. Mr. Joyce's presentation is entitled; "Extracorporeal Elimination of Circulating Exosomes as a Therapeutic Adjunct to Address Infectious Disease and Cancer." The presentation will highlight the clinical advancement of the Aethlon Hemopurifier® in treating hepatitis c virus (HCV) and discuss the opportunity to expand therapeutic indications to include cancer based on targeting the elimination of circulating tumor-secreted exosomes. The conference will be held at the Town and Country Resort Hotel in San Diego, California.

Aethlon is currently preparing to launch the first U.S. studies of Hemopurifier® therapy based on the recent approval of an Investigational Device Exemption (IDE) by the United States Food and Drug Administration (FDA). Under the IDE, Aethlon will enroll ten end stage renal disease (ESRD) patients infected with HCV as part of a feasibility study to demonstrate Hemopurifier safety. Successful completion of the feasibility study will set the stage for Aethlon to conduct pivotal studies required for market clearance to treat HCV and other disease conditions.
The conference abstract of the presentation follows:
Extracorporeal Elimination of Circulating Exosomes as a Therapeutic Adjunct to Address Infectious Disease and Cancer on 9/12/13 at 3:45pm pacific.
The Aethlon Hemopurifier® is a first-in-class device that targets the rapid elimination of infectious disease and cancer glycopathogens from circulation. In cancer, the Hemopurifier has been demonstrated to capture exosomes underlying lymphoma, melanoma, ovarian, and breast cancer. These microvesicular particles trigger apoptosis of immune cells and have been reported to facilitate tumor growth, metastasis, and the development of drug resistance.
In design, the Hemopurifier consists of the affinity lectin Galanthus nivalis agglutinin (GNA) immobilized in the outer-capillary space of plasma membrane technologies. The resulting mechanism provides selective target elimination as GNA binds high mannose signatures abundant on the surface of exosomes and viral glycoproteins. Studies of hepatitis c (HCV) infected patients receiving a three-treatment Hemopurifier protocol combined with interferon-based standard of care resulted in undetectable HCV in as little as seven days in hard-to-treat genotype-1 patients. The studies also documented the ability of the Hemopurifier to capture as many as 300 billion HCV copies during a single six- hour treatment. The FDA recently approved an IDE that allows for the initiation of US feasibility studies.
About Aethlon Medical
Aethlon Medical creates innovative medical devices that address unmet medical needs in cancer, infectious disease, and other life-threatening conditions. Our Aethlon ADAPT™ System is a revenue-stage technology platform that provides the basis for a new class of devices the rapid, yet selective removal of disease promoting particles from the entire circulatory system. At present, The Aethlon ADAPT™ product pipeline includes the Aethlon Hemopurifier® to address infectious disease and cancer, and a medical device being developed under a 5-year contract with Defense Advanced Research Projects Agency (DARPA) to reduce the incidence of sepsis in combat-injured soldiers. For more information, please visit www.aethlonmedical.com.
Certain statements herein may be forward-looking and involve risks and uncertainties. Such forward-looking statements involve assumptions, known and unknown risks, uncertainties and other factors which may cause the actual results, performance or achievements of Aethlon Medical, Inc. to be materially different from any future results, performance, or achievements expressed or implied by the forward-looking statements. Such potential risks and uncertainties include, without limitation, that the company can successfully protect its intellectual property, that removal of exosomes from the human body will impact or lead to successful treatment of cancer, or that exosomes are the cause of tumor growth and progression, that the FDA will not approve the initiation of the Company's clinical programs or provide market clearance of the company's products, future human studies whether revenue or non-revenue generating of the Aethlon ADAPT™ system or the Aethlon Hemopurifier® as an adjunct therapy to improve patient responsiveness to established cancer or hepatitis C therapies or as a standalone cancer or hepatitis C therapy, the Company's ability to raise capital when needed, the Company's ability to complete the development of its planned products, the Company's ability to manufacture its products either internally or through outside companies and provide its services, the impact of government regulations, patent protection on the Company's proprietary technology, product liability exposure, uncertainty of market acceptance, competition, technological change, and other risk factors. In such instances, actual results could differ materially as a result of a variety of factors, including the risks associated with the effect of changing economic conditions and other risk factors detailed in the Company's Securities and Exchange Commission filings. The Company undertakes no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events, or otherwise.
Contacts:
James A. Joyce
Chairman and CEO
858.459.7800 x301
jj@aethlonmedical.com
Jim Frakes
Chief Financial Officer
858.459.7800 x300
jfrakes@aethlonmedical.com
Marc Robins
877.276.2467
mr@aethlonmedical.com
Published at Investorideas.com newswire
Sign up for the free investor news and stock alerts
http://www.investorideas.com/Resources/Newsletter.asp
Disclaimer / Disclosure : The Investorideas.com is a third party publisher of news and research Our sites do not make recommendations, but offer information portals to research news, articles, stock lists and recent research. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. Disclosure: Investorideas has been compensated by AEMD for news distribution and content publishing: three thousand per month effective June 2013
http://www.investorideas.com/About/Disclaimer.asp
This site is currently compensated by featured companies, news submissions and online advertising.
BC Residents and Investor Disclaimer : Effective September 15 2008 - all BC investors should review all OTC and Pink sheet listed companies for adherence in new disclosure filings and filing appropriate documents with Sedar

Solar Stock XsunX, Inc. (OTCQB: XSNX) Industry Update: U.S. Market Installs 723 Megawatts in Q1 2013; Grows 33% Over Last Year

New York, NY, Point Roberts, WA - September 4, 2013 (Investorideas.com renewable energy newswire) Investorideas.com, an investor research portal specializing in investing ideas in leading sectors including renewable energy stocks, issues a corporate and industry update for solar stock, XsunX, Inc. (OTCQB: XSNX), entitled U.S. Market Installs 723 Megawatts in Q1 2013; Grows 33% Over Last Year.

Tom M. Djokovich, CEO of XsunX, Inc. (OTCQB: XSNX) said in the corporate/ industry update:
"As the headline above from a report offered by the Solar Energy Industries Association (SEIA) outlines, the solar industry is making tremendous and significant progress not just as a viable power production source, but as a sales and revenue source as well."
Continued…
For XsunX, this type of growth domestically, in addition to growth occurring internationally, provides an immense opportunity for the Company to diversify and leverage its knowledge and extensive contact base in the PV industry.
Over the past several newsletters, we have been outlining how XsunX is expanding our marketing and sales efforts to add solar business solutions to our service offerings. With these additions, we are working to take advantage of new sales and revenue generating opportunities.
As we move into September, our sales efforts will be multi-pronged. We will be working and meeting with prospective customers for our CIGSolar® manufacturing technology, and responding to quote requests for commercial and utility scale projects.
We believe that this expansion will increase exposure of our CIGSolar® and technology offerings, improve our opportunities to generate revenues in the near term, and by generating revenues, may reduce or eliminate dependency on equity capital to fund operations - a positive for all shareholders.
For more information on what we are doing, you can view a recent interview from last Friday on MoneyTV with our CEO, Tom Djokovich here.
In regards to updating the web site: our web designer is back from vacation and we are making good progress with the updates and plan to launch in the near future.
Source: http://216.171.160.215/news.php?nid=370
More About XsunX (OTCQB: XSNX)
XsunX, Inc. is working to commercialize a new manufacturing process to produce low cost, high efficiency thin-film Copper Indium Gallium (di) Selenide (CIGS) thin film solar cells. Our patent-pending processing technology, which we call CIGSolar®, focuses on the mass production of thin-film CIGS solar cells utilizing a proprietary multi-area thermal deposition process to minimize processing defects to create highly uniform CIGS films. These cells match silicon solar cell dimensions and can be offered as a non-toxic, high-efficiency and lowest-cost alternative to the use of silicon solar cells. The company is offering licenses for the use of the CIGSolar® process technology, and plans to generate revenue through licensing fees and manufacturing royalties for the use of the CIGSolar® technology.
For more information please call XsunX at 888-797-4527, or visit the company's website at www.xsunx.com
About InvestorIdeas.com:
InvestorIdeas.com is a leader in investor stock research by sector, featuring stock news, commentary and trading alerts in leading sectors including biotech, tech, mining, energy, water, renewable energy, beverage stocks and more.
Follow Investorideas.com on Twitter http://twitter.com/#!/Investorideas
Follow Investorideas.com on Facebook http://www.facebook.com/Investorideas
Follow Investorideas.com News on Linkedin.com/today at http://www.linkedin.com/today/investorideas.com
Sign up for solar and renewable energy stock news alerts
http://www.investorideas.com/Resources/Newsletter.asp
Become an Investorideas.com Member and access our 14 online stock directories 24/7 - water, renewable energy, mining stocks and more…
http://www.investorideas.com/membership/
Disclaimer/ Disclosure : The Investorideas.com newswire is a third party publisher of news and research Our sites do not make recommendations, but offer information portals to research news, articles, stock lists and recent research. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. Disclosure: Investorideas has been compensated by XSNX for news distribution averaging 1500 per month
http://www.investorideas.com/About/Disclaimer.asp
This site is currently compensated by featured companies, news submissions and online advertising.
BC Residents and Investor Disclaimer : Effective September 15 2008 - all BC investors should review all OTC and Pink sheet listed companies for adherence in new disclosure filings and filing appropriate documents with Sedar Global investors must adhere to regulations of each country.
800-665-0411 - Source - www.Investorideas.com

Getting the Most from your Risk Capital

September 3, 2013 (www.investorideas.com newswire) Risk Capital Investment: the aggressive pursuit of profits in new or high risk sectors, with some percentage of your investment capital, in order to offset low growth sectors and setbacks that occur as a natural part of investing in stocks and bonds. Without some higher risk higher reward holdings it is nearly impossible to keep your portfolio growing at a rate great enough to offset inflation and the myriad of taxes and fees associated with serious investing.

Just what percentage of your holdings should be higher risk is a matter of both opinion and individual risk tolerance. It is typically agreed that while it needs to be a part of any serious portfolio it should not make up the majority or anything close to the majority as a few bad days could erase years of hard work and leave you unable to recoup the losses in a timely manner due to insufficient capital remaining.
Many people are straying away from the fixed percentage rules of diversification. Logically, to say that it should be the same amount in all market types does not make any sense at all. There needs to be some common sense market timing strategy involved in these decisions. If your low risk savings, bonds, and T-bills are not doing a lot in terms of profit and the medium risk areas such as conservative stock holdings are anemic it is not a bad thing in all situations to add a few percentage points of your portfolio to a higher risk category to search for profits. At the same time if the stocks are volatile and have potential for large swings then it is already a higher risk/reward setting and cutting back on the “high risk” portion makes sense.
Since it is still basically accepted that in no situation should the high risk investments make up the majority of your investments, the question remains how do you make the most of that money? If an actively managed portfolio has a value of $50,000 even a relatively aggressive 20% to high risk investment leaves only $10k to use in search of the highest available profits. Even on a solid profitable success that obviously is limiting in total profit that you can achieve.
One area you might look into further if you are not already involved in the market if the Forex currency exchange market. The reason for this area is very simple. While in most risk investing you can only use the cash you have available, a quark of the Forex brokers is they offer leveraged accounts. What this means is you can use your cash to take a position and the broker will stand behind that cash for many times the amount of your actual investment. Amounts of leverage vary from broker to broker but 50x to 100x are common and greater amounts are not difficult to find.
How does the leverage work? If you had $10,000 in your account and find a position based on indicators in a platform such as the MT4 platform from www.alpari.com you feel comfortable with, you take a position on a currency pairing for $1000 of your money. By using the leverage provided by your broker, your actual position you are taking is (at 100x) $100,000. This has allowed you to use a small percentage of the smallest piece of your portfolio to make a move that is worth twice as much as your entire portfolio. The advantages in this are obvious.
What is the down side? The downside is very simple as well, and why caution, common sense, and sound research is essential. If you stand to make profits on a $100,000 investment you also stand to take the loss associated with the $100k. This is why you are using only a percentage of your risk capital, the rest must stay in reserve to cover a potential loss greater than the $1000 initially invested. The proven value of this however is when you make a good call and let it run you can realize very large profits quickly and on a scale that far exceed your individual investment power.
Source Reuben Dickison
Contact jumpwrite@gmail.com
G+ Profile link https://plus.google.com/114409964807024796247/posts

The Changing Face of Mobile Commerce/ Marketing; Stocks to Watch: (FB), (GOOG), (MM), (MBIT), (YELP)

Point Roberts, WA, New York, NY - September 3, 2013 (www.investorideas.com newswire) Investorideas.com staff: Investorideas.com, an investor research portal specializing in investing ideas in leading sectors including tech and mobile stocks, issues a news and trading alert for mobile commerce and mobile marketing stocks . As more and more consumers go mobile, the industry competition is heating up.

A recent article in Bizreport noted, "New data out from JiWire underlines the importance of mobile functionality for retail brands. According to the Q2 Mobile Audience Insights Report nearly half (42%) of shoppers prefer to research products via mobile while 45% prefer to purchase in-store.
At the same time, retail shoppers' engagement with ads has been shown to increase when they are within a 2 mile radius from a store location. Researchers found engagement was 42% higher when ads were seen on a device rather than when they were inside a store. According to the report, 92% more shoppers are now buying from a mobile device than in-store (versus Q1 2012).”
According to a recent press release from MobileBits Corporation (OTCBB: MBIT), "Mobile ad networks such as iAds (APPL) , Admob (GOOG) and Millennial Media (NYSE: MM) extend the digital advertising model by providing consumer clicks and typically charging a CPM (cost per thousand) or CPC (cost per click) fee to deliver leads and brand awareness. Social networks such as Facebook (FB), Yelp (NYSE: YELP) and to an extent Groupon (GRPN), offer increased consumer engagement through mobile apps providing an opportunity to monetize consumer clicks.
MobileBits (OTCBB: MBIT) says SAMY, its mobile marketing and engagement network, transcends the mobile ad and social app landscape by increasing the engagement value and moving more of the real-time controls directly into the hands of the advertiser, charging only for actionable results defined as subscriptions. SAMY is a fast growing 'Mobile Mall' that provides any merchant, retailer or brand with an out-of-the box, ready to deploy, mobile marketing & engagement solution to connect with consumers in their local area and help increase sales in the physical store.
On August 27th the company released its mobile storefront management tools designed to enable businesses to easily create their own mobile app presence and to connect with customers. The SAMY platform offers merchants a new and more effective solution to engage customers around their shopping interests.
MobileBits (OTCBB: MBIT) stock closed up 26% in Friday's trading session.
According to an article in Forbes, "Facebook (FB), also said it reached 1 million advertisers, an indication that it's becoming more successful in attracting small local businesses, aided particularly by a recent simplification of its ad offerings. Not least, Facebook and the ad firms that help marketers buy ads on the site say big brands are also increasing their spending.”
Yelp Inc. (NYSE: YELP) recently announced the availability of Yelp Brazil (http://www.yelp.com.br). Starting August 21st people throughout Brazil are able to create accounts on Yelp.com.br to share their opinions about great local businesses. Yelp's free iPhone and Android applications will be available as well as its free suite of business owner tools: Yelp for Business Owners (http://biz.yelp.com.br).
Millennial Media (NYSE: MM), a leader in mobile advertising recently announced that it has signed a definitive agreement to acquire privately-held, Boston-based Jumptap in a predominantly stock transaction. Jumptap is a mobile advertising platform, which recently has taken a programmatic and mobile-first approach to reaching audiences. Jumptap has an audience profile store with over 100 million unique, data-rich profiles, of which more than 44 million can be reached across various screens - online and mobile. Jumptap supports its audience targeting through partnerships with more than 20 third-party data providers. Jumptap also has 55 issued patents and more than 50 patents pending, covering broad aspects of the mobile advertising market.
Millennial Media's market leading platform will now include Jumptap's offerings, and will result in consolidation and differentiated scale in the fast-growing mobile ad market.
The company also announced a new strategic partnership with Adsmovil, the principal mobile ad network in Latin America and the U.S. Hispanic markets, extending its media platform into South America, Central America and Mexico.
For investors following mobile commerce, mobile marketing, mobile payments and mobile security, Investorideas.com offers a list of publicly trades stocks in addition to news and articles following key trends.
Article sources
http://www.bizreport.com/2013/08/jiwire-shoppers-turn-to-mobile-for-research-comparison.html
http://www.forbes.com/sites/roberthof/2013/07/24/facebooks-mobile-ads-jump-as-q2-earnings-beat-street/
About InvestorIdeas.com: Investor Ideas for global investors
www.InvestorIdeas.com is a meeting place for investors and public companies in leading sectors. Find investing ideas in biotech stocks, tech and mobile stocks, mining stocks, oil and gas, water stocks, renewable energy, beverage stocks, defense stocks, nanotech and more on TSX, OTC, NASDAQ and global exchanges.
The Investor Ideas newswire is a news source on Google news, Google Currents and Linkedin.com/Today news. Investorideas.com newswire is now available as a free mobile app for iPhone orAndroid. Go here or here for link
Follow Investorideas.com on Twitter 
Follow Investorideas.com on Facebook 
Follow Investorideas.com News on Linkedin.com/today
Sign up for free stock alerts at Investorideas.com
Become an Investorideas.com Member and access our online stock directories listing thousands of publicly traded stocks in over 14 leading sectors
Disclaimer/ Disclosure : The Investorideas.com is a third party publisher of news and research Our sites do not make recommendations, but offer information portals to research news, articles, stock lists and recent research. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities.
http://www.investorideas.com/About/Disclaimer.asp
This site is currently compensated by featured companies, news submissions and online advertising. Disclosure: MBIT pays Investorideas.com an average of $150 per news release. Investorideas.com was not compensated for this article.
BC Residents and Investor Disclaimer : Effective September 15 2008 - all BC investors should review all OTC and Pink sheet listed companies for adherence in new disclosure filings and filing appropriate documents with Sedar. Read for more info: http://www.bcsc.bc.ca/release.aspx?id=6894
800-665-0411 - Source - www.Investorideas.com

LOHAS Stock Alert: Microlog (OTC: MLOG) Announces Closing Of $300,000 Of Financing

BETHESDA, Md. - August 30, 2013 (Investorideas.com newswire) Microlog Delaware Corporation (OTC: MLOG) (the "Company") announced today that it has closed on $300,000 of financing for the Company. The financing took the form of a $300,000 convertible promissory note, convertible at the holder's option into Company restricted common stock at a fixed price of $.12 per share. The term of the note is 18 months and it carries a 9% coupon. The private investor also received 300,000 warrants to purchase Company common stock at $.12 per share.

"We are pleased to announce the closing of this important financing for our Company," said David Sackler, CEO of the Company. "The financing supports our wholly owned subsidiary Silverbow with working capital and strengthens our corporate liquidity. We are now looking for additional acquisitions in the natural and nutritional foods space to complement Silverbow as we grow our Company."
Forward-Looking Statements:
This release may contain forward-looking statements. Forward-looking statements involve known and unknown risks, uncertainties, and other factors, which may cause the actual results, performance, or achievements of NutraBev, Microlog, or Microlog Maryland to be materially different from any future results, performance, or achievements expressed or implied by the forward-looking statements. We undertake no obligation to update any forward-looking statements to reflect events or circumstances after the date of such statements.
Media Contact:
David Sackler
CEO
(516) 513-5113
dsackler@nutrabev.com
Disclaimer/ Disclosure: The Investorideas.com is a third party publisher of news and research Our sites do not make recommendations, but offer information portals to research news, articles, stock lists and recent research. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. This site is currently compensated by featured companies, news submissions and online advertising. Disclosure: Investorideas has been compensated for news publishing and content marketing : ( three thousand five hundred first month plus 17,500 restricted shares for month two) for two month period) http://www.investorideas.com/About/Disclaimer.asp
Warning this company is not fully reporting at this time: more info: http://www.otcmarkets.com/stock/MLOG/quote
BC Residents and Investor Disclaimer: Effective September 15 2008 - all BC investors should review all OTC and Pink sheet listed companies for adherence in new disclosure filings and filing appropriate documents with Sedar. Read for more info: http://www.bcsc.bc.ca/release.aspx?id=6894

MobileBits Holdings Corp (OTCBB:MBIT) provides valuable tools for merchants to create, publish & advertise on mobile devices

SARASOTA, Fla. - August 28, 2013 (www.investorideas.com newswire) via PRWEB - MobileBits, (OTCBB: MBIT), provider of the SAMY(TM) mobile marketing and engagement network, today released its mobile storefront management tools designed to enable businesses to easily create their own mobile app presence and to connect with customers. The SAMY platform offers merchants a new and more effective solution to engage customers around their shopping interests.

SAMY offers online tools to either create a new app or integrate existing app functionality into a customized branded mobile storefront. Merchants are able to create and publish exclusive campaigns and reconcile offer redemptions at the point-of-sale, helping drive more customers into the store.

"Samy is our most effective tool for coupon redemption," said Jan De Schepper, Marketing Director for McDonald's. "Samy has been a real asset for maintaining our relationships with customers when they're away from the stores."

Mobile ad networks such as iAds, Admob and Millennial Media extend the digital advertising model by providing consumer clicks and typically charging a CPM (cost per thousand) or CPC (cost per click) fee to deliver leads and brand awareness. Social networks such as Facebook, Yelp, and to an extent Groupon, offer increased consumer engagement through mobile apps providing an opportunity to monetize consumer clicks.

SAMY transcends the mobile ad and social app landscape by increasing the engagement value and moving more of the real-time controls directly into the hands of the advertiser, charging only for actionable results defined as subscriptions.

Mobile subscribers select and connect to branded merchant storefronts, opening up a direct channel of communication around product offers and loyalty rewards delivering tremendous value to the business in the form of unlimited offer impressions and clicks.

Today SAMY averages 45 percent offer-view rates and 20 percent offer-redemption rates in the stores. Thousands of stores and top brands have already selected SAMY including McDonald's, Chairman's Brands and Extreme Brandz, who was recently acquired by larger MTY Group in Canada - together totaling 30 QSR brands.

"The SAMY redemption rates are outstanding and demolish direct mail and flyer campaigns," said Norm Pickering, Head Marketing North America at Extreme Brandz.

SAMY is a performance driven engagement network and charges merchants pennies for making the connection between interested shoppers and local merchants on their mobile devices. Merchants simply publish their content and advertise their brand within the SAMY network, which is comprised of consumers who are collectively aggregated from each enrolled client brand.

For merchants interested in creating their own free branded mobile storefront in SAMY, go to http://www.samy.com/getstarted and Get Started Now!

About MobileBits Corporation

MobileBits, provider of SAMY, the fast growing 'Mobile Mall' that provides any merchant, retailer or brand with an out-of-the box, ready to deploy, mobile commerce platform to connect with consumers in their local area and help increase sales in the physical store. The solution provides businesses a complete set of tools to connect with, create and manage mobile campaigns, deals, offers, commerce, loyalty and rewards to a subscribed mobile consumer. For more information, visit http://www.mobilebits.com or http://www.samy.com.

Forward-Looking Safe Harbor Statement

This press release contains forward-looking statements that are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. By their nature, forward-looking statements and forecasts involve risks and uncertainties because they relate to events and depend on circumstances that will occur in the near future. There are a number of factors that could cause actual results and developments to differ materially from forecasted results. These risks and uncertainties include our ability to: attract end users; attract advertisers; our ability to successfully implement our current long-term growth strategy; as well as product demand, market competition, fluctuations in advertising payouts, delays in website & application development, technical issues beyond our control, reliance on the various platforms that we build applications on, and risks inherent in our operations. For a discussion of these risks and uncertainties, please see our filings with the Securities and Exchange Commission. Our public filings with the SEC are available from commercial document retrieval services and at the website maintained by the SEC at http://www.sec.gov.

This article was originally distributed on PRWeb. For the original version including any supplementary images or video, visit http://www.prweb.com/releases/2013/7/prweb10942190.htm

Contact:

MobileBits Corporation
JoLynn Blatz
jolynn.blatz@mobilebits.com
941.225.6103

Published at Investorideas.com newswire

Disclaimer / Disclosure : The Investorideas.com is a third party publisher of news and research Our sites do not make recommendations, but offer information portals to research news, articles, stock lists and recent research. Nothing on our sites should be construed as an offer or solicitation to buy or sell products Or securities. Investorideas.com was compensated one hundred fifty dollars for this single news release.

http://www.investorideas.com/About/Disclaimer.asp

This site is currently compensated by featured companies, news submissions and online advertising.

BC Residents and Investor Disclaimer: Effective September 15 2008 - all BC investors should review all OTC and Pink sheet listed companies for adherence in new disclosure filings and filing appropriate documents with Sedar. Read for more info: http://www.bcsc.bc.ca/release.aspx?id=6894

Biometrics/ Mobile Security Stock Investor Alert (OTCQB: NXTD): Information Available Through S&P Capital IQ Corporation Records Program for Biometric Company NXT-ID, Inc.

Shelton, CT - August 28, 2013 (Investorideas.com biometrics/ defense stocks newswire) NXT-ID, Inc. (OTCQB:NXTD) a biometrics company focused on the growing m-commerce market announces today that its company information would be made available via S&P Capital IQ Corporation Records Listing Program. As part of the program, a full description of NXT-ID, Inc. will be published in the Daily News Section of Standard & Poors's Corporation Records, a recognized securities manual for secondary trading in up to 38 States under the Blue Sky Laws. S&P Capital IQ Corporation Records is available in print, CD-ROM, and via the web at www.netadvantage.standardandpoors.com as well as through numerous electronic vendors.

The company information about NXT-ID, Inc. to be made available through this program includes an in-depth description of the company's business operations, share price, dividend history, shares outstanding, company financial position, earnings, and full income statement and balance sheet.
About NXT- ID Inc. - Mobile Security for a Mobile World
NXT-ID, Inc.'s (OTCQB: NXTD) innovative MobileBio™ solution mitigates consumer risks associated with mobile computing, m-commerce and smart OS-enabled devices. The company is focused on the growing m-commerce market, launching its innovative MobileBio™ suite of biometric solutions that secure consumers' mobile platforms. NXT-ID' wholly owned subsidiary, 3D-ID LLC, is engaged in biometric identification has 22 licensed patents in the field of 3D facial recognition http://www.nxt-id.com/, http://3d-id.net/
About S&P Capital IQ
S&P Capital IQ, a part of McGraw Hill Financial, is a leading provider of multi-asset class and real time data, research and analytics to institutional investors, investment and commercial banks, investment advisors and wealth managers, corporations and universities around the world. Evaluated pricing is prepared by Standard & Poor's Securities Evaluations, Inc., a part of S&P Capital IQ and a registered investment adviser with the U.S. Securities and Exchange Commission. In the United States, research reports are prepared by Standard & Poor's Investment Advisory Services LLC, a part of S&P Capital IQ and a registered investment adviser with the U.S. Securities and Exchange Commission. S&P Capital IQ provides a broad suite of capabilities designed to help track performance, generate alpha, and identify new trading and investment ideas, and perform risk analysis and mitigation strategies. Through leading desktop solutions such as the S&P Capital IQ, Global Credit Portal and MarketScope Advisor desktops; enterprise solutions such as S&P Capital IQ Valuations; and research offerings, including Leveraged Commentary & Data, Global Markets Intelligence, and company and funds research, S&P Capital IQ sharpens financial intelligence into the wisdom today's investors need. For more information visit: www.spcapitaliq.com
Company information distributed through the Corporation Records Program is based upon information that S&P Capital IQ considers to be reliable, but neither S&P Capital IQ nor its affiliates warrant its completeness or accuracy, and it should not be relied upon as such. This material is not intended as an offer or solicitation for the purchase or sale of any security or other financial instrument.
Contact:
Corporate info: info@nxt-id.com
Investor Relations
Jared Mitchell
Managing Director
ProActive Capital
www.ProActiveCapital.com
Direct: 646.863.6274
Cell: 917.453.0637
jmitchell@proactivecapital.com
S&P Capital IQ Customer Contact:
Richard Albanese
212 438-3647
S&P Capital IQ Media Relations
Michael Privitera
212 438-6679
Published at the Investorideas.com Newswire - Big ideas for Global Investors
Disclaimer/ Disclosure: The Investorideas.com newswire is a third party publisher of news and research as well as creates original content as a news source. Original content created by investorideas is protected by copyright laws other than syndication rights. Investorideas is a news source on Google news and Linkedintoday plus hundreds of syndication partners. Our site does not make recommendations for purchases or sale of stocks or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investment involves risk and possible loss of investment. This site is currently compensated by featured companies, news submissions, content marketing and online advertising. Contact each company directly for press release questions. Disclosure is posted on each release if required but otherwise the news was not compensated for and is published for the sole interest of our readers. Disclosure: this release was compensated for by NXTD as part of a monthly service for news publication and distribution and content marketing. (five thousand per month plus 144 shares)
More disclaimer info: http://www.investorideas.com/About/Disclaimer.asp
BC Residents and Investor Disclaimer: Effective September 15 2008 - all BC investors should review all OTC and Pink sheet listed companies for adherence in new disclosure filings and filing appropriate documents with Sedar. Read for more info: http://www.bcsc.bc.ca/release.aspx?id=6894. Global investors must adhere to regulations of each country.

Two Visions, One Future: Overcoming the Global Barriers to Connect the World

Point Roberts WA, New York, NY - August 27, 2013 (Investorideas.com newswire) Investorideas.com, providing global investing ideas in leading sectors including tech, features a snapshot of how two visionaries (Mark Zuckerberg & Dr Payne) in the tech space are dedicated to breaking language and communication barriers around the world.

Mark Zuckerberg, founder and CEO of Facebook (NASDAQ:FB) announced last week the launch of internet.org , a global partnership with the goal of making internet access available to the next 5 billion people.
"Everything Facebook has done has been about giving all people around the world the power to connect," Zuckerberg said. "There are huge barriers in developing countries to connecting and joining the knowledge economy. Internet.org brings together a global partnership that will work to overcome these challenges, including making internet access available to those who cannot currently afford it."
Today, only 2.7 billion people -- just over one-third of the world's population -- have access to the internet. Internet adoption is growing by less than 9 percent each year, which is slow considering how early we are in its development.
The goal of Internet.org is to make internet access available to the two-thirds of the world who are not yet connected and to bring the same opportunities to the other 67% of world today that is not connected.
Today only 50-80 languages are supported on the Internet out of potentially 2000+ written “native” languages that are used right now. Years ago a software company dedicated to language saw the future without knowing it.
Dr. Philip Payne, the founder of Linguist's Software Inc. ( http://www.linguistsoftware.com ) , started his company 30 years ago out of a love of language and a hope that his software would break language barriers globally. Today his fonts and keyboard input software can accommodate over 2000+ languages; dramatic growth from his product launch with just over 200 fonts over two decades ago and now it is the only worldwide language IP in existence.
Ken Kinkel, CEO & Chairman, of C·M&A ( www.CorpMA.com ), who is handling Linguist’s Software sale, recently commented, “Dr. Payne has created over 50 million+ bibles in languages never made available before and now he is opening the whole world to digital communications, and in all languages, after starting from simple and humble beginning. Quietly he has become the world leader with ten times more languages than any of us ever thought were available. We are amazed at his devotion, his writing, his world influences and overwhelming contributions to mankind.”
Dr. Philip Payne, the founder and President of Linguist's Software, Inc., is a specialist in New Testament Studies. (Ph.D. The University of Cambridge). He is well known for his studies on New Testament Textual Criticism, the Parables of Jesus, and Man and Woman in the Teachings of Paul. He and his wife Nancy were missionaries in Japan with the Evangelical Free Church, where they ministered to students in the Kyoto Christian Studies Center and lectured on New Testament in various Japanese Seminaries. They have three children David, Kimiko, and Brendan.
NY Times article links:
Linguist's Software:
http://www.nytimes.com/ 1994/05/22/business/ technology-for-mac-users-software- for-typing-in-tongues.html
internet.org:
http://www.nytimes.com/ 2013/08/21/technology/ facebook-leads-an-effort-to-lower- barriers-to-internet-access.html?hp
Contact for more info on Linguist's Software, Inc .
Ken Kinkel, CEO & Chairman
Corporate Mergers & Acquisitions
C·M&A / www.CorpMA.com
email: CEO@CorpMA.com
855-559-0100 ext 11
About InvestorIdeas.com: Big ideas for global investors
InvestorIdeas.com is a leader in investor stock research by sector, featuring stock news, commentary and trading alerts in leading sectors including biotech, tech, mining, energy, water, renewable energy, beverage stocks and more.
Disclaimer/ Disclosure: The Investorideas.com newswire is a third party publisher of news and research Our sites do not make recommendations, but offer information portals to research news, articles, stock lists and recent research. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. Disclosure: Investor ideas has been compensated for this article distribution. More info: http://www.investorideas.com/About/Disclaimer.asp
Source: www.Investorideas.com